Literature DB >> 8763591

[Digestive amines of bacterial origin and behavior disorders. Apropos of a case].

J M Gabastou1, L Nugon-Baudon, Y Robert, C Manuel, P Vaissade, E Bourgeon, M Sibeud, O Szylit, P Bourlioux.   

Abstract

Implication of amines in central nervous system diseases such as migraine, Parkinson disease, epilepsy and depressive illness, is well established. On an other hand, intestinal flora is responsible for the production of specific metabolites such as amines, particularly histamine, tyramine, putrescine and cadaverine. These amines can be absorbed in situ and, through unknown mechanisms, may affect the host's behavior. Most of the data about the pathological activities of bacterial amines concern animals. The concentrations of histamine, tyramine, putrescine and cadaverine in the feces of the studied "controls" appeared steady over time. For the patient presenting clastic crisis without any starting factor, variations appear to overcome the "controls" values, with a great variability. At least tyramine, putrescine and cadaverine concentrations variations are striking by superposed and seem associated to the arising hyper agressivity crisis.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8763591

Source DB:  PubMed          Journal:  Pathol Biol (Paris)        ISSN: 0369-8114


  3 in total

1.  Variations in digestive physiology of rats after short duration flights aboard the US space shuttle.

Authors:  S Rabot; O Szylit; L Nugon-Baudon; J C Meslin; P Vaissade; F Popot; M Viso
Journal:  Dig Dis Sci       Date:  2000-09       Impact factor: 3.199

2.  Oral Administration of Semicarbazide Limits Weight Gain together with Inhibition of Fat Deposition and of Primary Amine Oxidase Activity in Adipose Tissue.

Authors:  Josep Mercader; Zsuzsa Iffiú-Soltész; Sandy Bour; Christian Carpéné
Journal:  J Obes       Date:  2011-02-08

3.  Biogenic Amines: Signals Between Commensal Microbiota and Gut Physiology.

Authors:  Nobuyuki Sudo
Journal:  Front Endocrinol (Lausanne)       Date:  2019-07-31       Impact factor: 5.555

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.